Jacobsen L, Hermann M, Vieira P M, Schneider W J, Nimpf J
Department of Molecular Genetics, University and Biocenter Vienna, Austria.
J Biol Chem. 1995 Mar 24;270(12):6468-75. doi: 10.1074/jbc.270.12.6468.
alpha 2-Macroglobulin (alpha 2M), a major plasma component in all vertebrates, is proposed to function as a broad spectrum protease inhibitor. The alpha 2M-proteinase complex (activated alpha 2M; alpha 2M*) is removed rapidly by receptor-mediated endocytosis in the liver. Here we demonstrate by Western blotting that alpha 2M is also present in the yolk of chicken oocytes. Plasma levels of alpha 2M are increased by estrogen, and yolk alpha 2M is partially proteolyzed, consistent with the action of cathepsin D on endocytosed alpha 2M. Two known estrogen-induced ligands of the oocyte-specific 95-kDa very low density lipoprotein/vitellogenin receptor (OVR) are also fragmented by yolk cathepsin D (Retzek, H., Steyrer, E., Sanders, E. J., Nimpf, J., and Schneider, W. J. (1992) DNA Cell Biol. 11, 661-672). Since these findings suggested a common uptake mechanism for lipoproteins and alpha 2M by oocytes, we investigated whether OVR, a member of the low density lipoprotein receptor family, functions in the metabolism of alpha 2M. Ligand blotting of oocyte membrane extracts with chicken alpha 2M* revealed that it binds to OVR. Surprisingly, the oocyte receptor also recognizes native alpha 2M, in sharp contrast to the hepatic receptor, which only binds alpha 2M*. Receptor interaction of both forms requires Ca2+; however, competition experiments suggest that alpha 2M and alpha 2M* interact with slightly different, or overlapping, sites on the receptor. Colocalization of alpha 2M and OVR in coated vesicles isolated from growing oocytes, and internalization and degradation of methylamine-activated alpha 2M by COS-7 cells transfected with OVR, strongly suggest that alpha 2M is transported into growing oocytes via OVR. We propose that this multifunctional receptor mediates pathways at the metabolic crossroads of lipoproteins and protease inhibitor complexes.
α2-巨球蛋白(α2M)是所有脊椎动物血浆中的主要成分,被认为具有广谱蛋白酶抑制剂的功能。α2M-蛋白酶复合物(活化的α2M;α2M*)在肝脏中通过受体介导的内吞作用迅速被清除。在此,我们通过蛋白质印迹法证明α2M也存在于鸡卵母细胞的卵黄中。雌激素可使血浆中α2M的水平升高,并且卵黄中的α2M会发生部分蛋白水解,这与组织蛋白酶D对内吞的α2M的作用一致。卵母细胞特异性的95 kDa极低密度脂蛋白/卵黄生成素受体(OVR)的两种已知的雌激素诱导配体也会被卵黄组织蛋白酶D切割(雷茨克,H.,施泰勒,E.,桑德斯,E.J.,宁普夫,J.,和施耐德,W.J.(1992年)《DNA与细胞生物学》11,661 - 672)。由于这些发现提示卵母细胞对脂蛋白和α2M具有共同的摄取机制,我们研究了低密度脂蛋白受体家族成员OVR是否在α2M的代谢中发挥作用。用鸡α2M对卵母细胞膜提取物进行配体印迹分析表明它与OVR结合。令人惊讶的是,卵母细胞受体也能识别天然的α2M,这与肝脏受体形成鲜明对比,肝脏受体仅结合α2M。两种形式与受体的相互作用都需要Ca2+;然而,竞争实验表明α2M和α2M*与受体上略有不同或重叠的位点相互作用。从生长中的卵母细胞分离的被膜小泡中α2M和OVR的共定位,以及用OVR转染的COS - 7细胞对甲胺活化的α2M的内化和降解,强烈表明α2M是通过OVR转运到生长中的卵母细胞中的。我们提出这种多功能受体介导脂蛋白和蛋白酶抑制剂复合物代谢交叉点处的途径。